首页> 外文期刊>Coordination chemistry reviews >Binding and transport of aluminum by serum proteins
【24h】

Binding and transport of aluminum by serum proteins

机译:血清蛋白与铝的结合和转运

获取原文
获取原文并翻译 | 示例
       

摘要

There is a broad consensus that most of the aluminum in serum is bound to protein. A series of ultrafiltration studies indicate that about 85%-90% of the aluminum in normal serum is protein bound. This percentage drops to about 80% in uremic serum. It appears that most, if not all, of this aluminum is bound to the iron transport protein transferrin, which has an aluminum binding constant of about 10~(13). The Al-transferrin complex binds to the transferrin receptor, and receptor-mediated cellular uptake appears to be an important factor in the uptake of aluminum by other tissues, including brain. There have been reports that aluminum is also bound in serum to albumin. While there is evidence for weak binding of aluminum to purified albumin, there is still no convincing evidence that albumin binds a significant amount of aluminum in serum. Administration of the iron chelator desferrioxamine (DFO) results in a sharp increase in ultrafilterable aluminum in serum. This is usually attributed to the formation of the very stable Al-DFO complex. However, some research groups have proposed that the administration of desferrioxamine results in the complexation of aluminum by either an 18 kDa protein named albindin, or by an even smaller 8 kDa protein.
机译:人们普遍认为,血清中的大多数铝都与蛋白质结合。一系列超滤研究表明,正常血清中约85%-90%的铝与蛋白质结合。在尿毒症血清中该百分比下降至约80%。似乎大多数(如果不是全部)这种铝都与铁转运蛋白运铁蛋白结合,铁转运蛋白的铝结合常数约为10〜(13)。 Al-运铁蛋白复合物与运铁蛋白受体结合,受体介导的细胞摄取似乎是包括大脑在内的其他组织摄取铝的重要因素。已有报道铝也与白蛋白结合在血清中。尽管有证据表明铝与纯化的白蛋白结合较弱,但仍没有令人信服的证据表明白蛋白与血清中的大量铝结合。铁螯合剂去铁胺(DFO)的使用会导致血清中超滤铝的急剧增加。这通常归因于非常稳定的Al-DFO配合物的形成。然而,一些研究小组提出,去铁胺的施用导致铝通过一种18 kDa的蛋白albindin或什至更小的8 kDa的蛋白络合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号